drug development

In November, the WHO recommended a triple-drug therapy to eliminate elephantiasis. Representative image. Credit: Pixabay

What’s a Better Way To Finance Drug Dev – Open Source or Patent Financing?

Dean Baker 02/04/2021

Drugs are rarely expensive to manufacture and distribute, and...

pexels-karolina-grabowska-4210551f

The World Has a Safe and Effective COVID-19 Vaccine – but Challenges Remain

Souro Chowdhury 22/12/2020

Pfizer's and Moderna's successes have shown that mRNA technology...

analysis-2030265_1920

COVID-19: A Strong Scientific Workforce Is Our Best Insurance Against Adversity

Ram Ramaswamy 09/04/2020

There is no substitute for generously funding research at...

Department of Science and Technology, Department of Biotechnology, QuEST, quantum computing, Indian quantum computing, 3D printing, internet of things, artificial intelligence, data is the new oil, #Budget2020, 2020 union budget, R&D, Department of Space, Chandrayaan 3, Gaganyaan, human spaceflight, Indian Space Research Organisation, ISRO, Aditya L1, Renu Swarup, quantum cryptography,

The State Helps Float Risky Medical Research. Why Don’t Patents Benefit It?

Dr Samir Malhotra 26/12/2019

Before pharma companies can build on existing knowledge to...

antibiotic resistance, antimicrobial resistance, carbapenem, colistin, poultry antibiotics, fluoroquinolones, Acinetobacter baumannii, superbugs, Centre for Disease Dynamics, Economics and Policy, blaNDM-1, metallo-beta-lactamase, Drug Controller General of India, Drugs and Cosmetics Act, sanitation, open defecation, drinking water, Ayushman Bharat, drug development,

No Local Woe, India’s Poor Public Health Feeds Antibiotic Resistance Worldwide

T.V. Padma 13/02/2019

The spread of resistance is more acute in places...

M_Id_444668_malaria_vaccine

CSIR Lab Working on Developing Malaria Vaccine

Sunderarajan Padmanabhan 03/04/2018

The team, led by Puran Sijwali, looks to target...